(Date:9/5/2008)...you need to know what triggers them, experts say ...If you are one of the 36 million Americans who suf...he United States that is free from pollen and othe...lergies don,t only happen in the spring, they can ...l, the most challenging cities to live in are Gree...
(Date:9/5/2008)...ewswire-USNewswire/ -- Speaker Nancy Pelosi,issued...ims of the "Stand,Up to Cancer" telethon, to be ai...son in our country who has not seen a loved one,su...cans annually, and each,year there are more than 1...ther to make eradicating the scourge of cancer a n...
(Date:9/5/2008)... /PRNewswire/ -- On Saturday, September 6, PARI,Re... Network show Today,s,Family as part of their "Bre...ing medical device company that provides patients,... and compressors that deliver needed,medications d...the lives of those affected by respiratory,disease...
(Date:9/5/2008)...ewswire-USNewswire/ -- As the general election,cam...tion of Independent,Business ( http://www.nfib.com...or a greater focus on the healthcare concerns of s...can conventions are over, NFIB,is asking both cand... faced,by small businesses as they further develop...
Breaking Medicine News(10 mins):Health News:No Place Safe From Allergies 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3(Date:9/4/2008)...a Announcements Remain on Schedule with Two Abstra...cal Data Release in November 2008, BRIDGEWATER, N...als,Inc., a specialty pharmaceutical company focu...ic disease, today announced the appointment of,Pet...rectors., Peter Garrambone,s career includes more...
(Date:9/3/2008)... says: Wrong Question Asked. Wrong Children Studie... /PRNewswire-USNewswire/ -- A Centers for Disease,...claims there is no link,between the MMR vaccine an...ys this study does nothing to dispel the growing p... raises several questions concerning design,and me...
(Date:9/3/2008)...American College of Rheumatology Research and Educ...ds Significant Advances in Detecting, ...ept. 3 /- For the first time during i...umatoid arthritis, the,American College of Rheumat...ng new information acquired from research funded b...
(Date:9/3/2008)... September is National Vascular Disease Awaren...ire/ -- Diffusion Pharmaceuticals,LLC, a clinical-... drugs,for the treatment of unmet medical needs, a...s in a Phase I/II clinical trial of its lead drug,...l, designated NCT00725881,on the clinicaltrials.go...
Breaking Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Saltwater crocodiles can find their way home 565 1Saltwater crocodiles can find their way home 565 2PIP A Revolution in Stress Management 2044 1PIP A Revolution in Stress Management 2044 2PIP A Revolution in Stress Management 2044 3Study expected to boost research for hearing and balance therapies 2042 1Study expected to boost research for hearing and balance therapies 2042 2Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties 2037 1Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties 2037 2Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties 2037 3..., March 12, 2007 /PRNewswire-FirstCall/ - Chemokin...the "Company") , a,biotechnology company developin... disorders, and vascular disease today announced,p...tion of the,dose-escalation portion of its Phase I...nti-cancer drug candidate. No dose,limiting toxici...
...enic for Human TNFa, LAUSANNE, Switzerland, March ...arm), a global independent biopharmaceutical,devel...s medical,conditions, announces the presentation o...of action of Debio-0512 as an anti-TNFa,therapeuti... animal,models of acute and chronic inflammation. ...
Other Medicine Technology:Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2With its wide orifice tip, the Finntip Wide is designed especially for pipetting fragile cell suspensions and macromolecules like genomic DNA. This tip eliminates the mechanical shearing that causes
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
Volume range 1-5 ml. Designed for use with large laboratory vessels.
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
Medicine Products: